Ube Corporation · TSE:4208
Ube — Q2 FY2017 Earnings Presentation
28 slides from Ube's earnings presentation, Nov 1, 2017
Slide 1: Financial Results for the 2nd Quarter FY 2017
1 Financial Results for the 2nd Quarter FY 2017 November 1, 2017
Slide 2: Contents
2 Contents ・ FY2017 2nd Quarter Consolidated Results ・ FY2017 Consolidated Forecasts ・ Reference ※This"2nd Quarter(2Q)" date states information for 6 month total.
Slide 3: FY2017 2nd Quarter Consolidated Results
3 FY2017 2nd Quarter Consolidated Results
Slide 4: Scope of Consolidation
4 Scope of Consolidation - Financial Results for the 2nd Quarter FY2017 - End of FY2016 End of FY2017 2Q Difference Item Notes (A) (B) （B) - （A) Number of + UBE (Shanghai) LTD. consolidated 70 70 0 － Fukusei Tech Co.,Ltd subsidiaries Number of － UBE (Shanghai) LTD. equity method 25 23 -2 － Samekawa
Slide 5: Environmental Factors: Naphtha Material Price
5 Environmental Factors - Financial Results for the 2nd Quarter FY2017 - FY2016 2Q FY2017 2Q Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 105.3 111.1 5.8 398 463 65 Naphtha CIF $/ｔ 31,400 37,700 6,300 Material Price Domestic Yen/KL Benzene(ACP) $/ｔ 637 777 140 Australian $/ｔ 71.8 100.3 28.5
Slide 6: Major P/L & B/S Items
6 Major P/L ＆ B/S Items - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2016 2Q FY2017 2Q Difference Item (A) (B) (B) - (A) Net sales 281.0 327.1 46.0 Operating profit 11.5 22.6 11.1 Ordinary profit 10.3 23.7 13.4 Profit attributable to owners of parent 7.1 15.7 8.6 End of FY201
Slide 7: Net Sales by Segment
7 Net Sales by Segment - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2016 2Q FY2017 2Q Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 10.0, Synthetic rubber 10.3, Chemicals 117.9 146.3 28.3 Battery Materials and Fine Chemicals 2.8, Polyimide and Spe
Slide 8: Operating Profit by Segment
8 Operating Profit by Segment - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2016 2Q FY2017 2Q Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 5.5, Chemicals 0.4 13.3 12.8 Synthetic rubber 5.0, Polyimide and Specialty Products 2.2, etc Pharmaceutical
Slide 9: Analysis of Operating Profit
9 Analysis of Operating Profit - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) Operating profit Variance Segment FY2016 2Q FY2017 2Q Difference Sales Fixed Price Others volume Cost (A) (B) (B) - (A) *1 *2 Chemicals 0.4 13.3 12.8 8.1 2.7 2.1 -0.0 Pharmaceutical 1.1 1.6 0.5 0.1 0.9
Slide 10: Non Operating Income/Expenses
10 Non Operating Income/Expenses - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2016 2Q FY2017 2Q Difference Item (A) (B) (B) - (A) Operating profit 11.5 22.6 11.1 Net interest expenses -0.1 0.1 0.3 Share of profit of entities income/expenses Non-operating accounted for using 0
Slide 11: Extraordinary Income/Losses
11 Extraordinary Income/Losses - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2016 2Q FY2017 2Q Difference Item (A) (B) (B) - (A) Loss on disposal of PP&E -0.5 -0.4 0.0 Others 0.0 -0.0 -0.0 Extraordinary income/losses -0.4 -0.4 0.0
Slide 12: Operating Profit - Net Income
12 Operating Profit - Net Income - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2016 2Q FY2017 2Q Difference Item (A) (B) (B) - (A) Operating profit 11.5 22.6 11.1 Non-operating income/expenses -1.1 1.1 2.3 Ordinary profit 10.3 23.7 13.4 Extraordinary income/losses -0.4 -0.4 0.
Slide 13: Consolidated Balance Sheet
13 Consolidated Balance Sheet - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) End of FY2016 End of FY2017 2Q Difference Item (A) (B) (B) - (A) Current assets 295.0 305.4 10.3 Fixed assets 414.2 416.7 2.4 Total assets 709.3 722.3 12.9 Interest-bearing debts 210.4 207.5 -2.8 Other l
Slide 14: Consolidated Statements of Cash Flows
14 Consolidated Statements of Cash Flows - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) Item FY2016 2Q FY2017 2Q Profit before income taxes 23.2, A.Cash flows from operating activities 26.0 31.0 Depreciation and amortization 17.2, Payment of Tax and others -4.9, etc. B.Cash flows
Slide 15: FY2017 Consolidated Forecasts
15 FY2017 Consolidated Forecasts
Slide 16: Scope of Consolidation - FY2017 Forecasts
16 Scope of Consolidation - FY2017 Consolidated Forecasts - End of End of Difference Item FY2016 FY2017 Notes (A) (B) （B) - （A) Number of + UBE (Shanghai) Ltd. consolidated 70 70 0 － Fukusei Tech Co.,Ltd subsidiaries Number of + Joint venture of electrolyte business in China equity method 25 24 -1 －
Slide 17: Environmental Factors: Naphtha Material Price
17 Environmental Factors - FY2017 Consolidated Forecasts - End of End of Difference Item FY2016 FY2017 (A) (B) (B) - (A) Exchange Rate Yen/$ 108.4 110.5 2.1 [110.0] 482 Naphtha CIF $/ｔ 430 52 [500] 39,000 Material Price Domestic Yen/KL 34,500 4,500 [40,200] 764 Benzene(ACP) $/ｔ 723 41 [750] 104.1 Au
Slide 18: Major P/L & B/S Items - FY2017 Forecasts
18 Major P/L ＆ B/S Items - FY2017 Consolidated Forecasts - (Billions of yen) FY2016 FY2017 Difference Item (A) (B) (B) - (A) Sales 616.5 685.0 68.5 Operating profit 34.9 45.0 10.1 Ordinary profit 33.3 45.0 11.7 Profit attributable to owners of parent 24.1 29.0 4.9 End of FY2016 End of FY2017 Differe
Slide 19: Net Sales by Segment - FY2017 Forecasts
19 Net Sales by Segment - FY2017 Consolidated Forecasts - (Billions of yen) FY2016 FY2017 Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 8.3 Synthetic rubber 11.1 Chemicals 258.3 295.0 36.7 Battery Materials and Fine Chemicals 6.4, Polyimide and Specialty Products 3.7, et
Slide 20: Operating Profit by Segment - FY2017 Forecasts
20 Operating Profit by Segment - FY2017 Consolidated Forecasts - (Billions of yen) FY2016 FY2017 Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 3.5 Synthetic rubber 6.1 Chemicals 9.6 23.5 13.9 Battery Materials and Fine Chemicals 1.7, Polyimide and Specialty Products 2.1,
Slide 21: Operating Profit - Net Income - FY2017 Forecasts
21 Operating Profit - Net Income - FY2017 Consolidated Forecasts - (Billions of yen) FY2016 FY2017 Difference Item (A) (B) (B) - (A) Operating profit 34.9 45.0 10.1 Non-operating income/expenses -1.6 0.0 1.6 Ordinary profit 33.3 45.0 11.7 Extraordinary income/losses -0.4 -3.5 -3.1 Profit before inco
Slide 22: Reference
22 Reference UBE
Slide 23: Reference: Progress of Major P/L Items
23 【Reference】 Progress of Major P/L Items - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2016 (A) FY2017 (B) Difference (B) - (A) 項 目 2Q 2Q 2Q （Progress） （Progress） 281.0 327.1 Net sales 616.5 685.0 68.5 46.0 (45.6%) (47.8%) 11.5 22.6 Operating profit 34.9 45.0 10.1 11.1 (32.9
Slide 24: Reference: Progress of Net Sales by Segment
24 【Reference】 Progress of Net Sales by Segment - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2017 Full-year Progress Segment 1Q 2Q 3Q 4Q Total (forecast) % Chemicals 73.3 72.9 - - 146.3 295.0 49.6% Pharmaceutical 2.4 2.6 - - 5.1 10.0 51.0% Cement & Construction 57.2 58.7 - -
Slide 25: Reference: Progress of Operating Profit by Segment
25 【Reference】 Progress of Operating Profit by Segment - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2017 Full-year Progress Segment 1Q 2Q 3Q 4Q Total (forecast) % Chemicals 6.1 7.1 - - 13.3 23.5 56.6% Pharmaceutical 0.7 0.8 - - 1.6 2.0 80.0% Cement & Construction 2.4 3.3 - -
Slide 26: Reference: Consolidated Key Indicators
26 【Reference】 Consolidated Key Indicators - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) FY2017 full-year Item FY2016 2Q FY2017 2Q FY2016 full-year (forecast) Capital investment 18.3 13.8 42.0 44.0 Depreciation and amortization 16.8 17.2 35.0 34.4 R&D expenses 6.5 6.4 14.5 13.6
Slide 27: Reference: Major Subsidiaries
27 【Reference】 Major Subsidiaries - Financial Results for the 2nd Quarter FY2017 - (Billions of yen) Operating Sales Subsidiaries and affiliates Business profit Difference from FY2017 2Q FY2016 2Q UBE CHEMICALS (ASIA) PUBLIC CO., LTD Manufacture and sales of caprolactam, ammonium sulfate, and nylon
Slide 28: Forward-looking statements notice
28 This presentation material contains forward-looking statements concerning UBE’s future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently availab